Latanoprost

Embed this Topic
Latanoprost (pronounced la-TA-noe-prost) ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes (through the uvealsclearal tract). It is also known by the brand name of Xalatan manufactured by Pfizer. Annual sales are approximately $1.6 billion. The patent... more
Read article at Wikipedia

Also known as:

  • Xalatan

Medicine

ATC Code:

  • S01EE01

Drugbank:

  • APRD01065

Pubchem:

  • 60,798

CAS Number:

  • 130209-82-4

Route of administration:

Used To Treat:

top ↑

Facts from the Community

From the BioVenturist base

Technology involved:

Sales:

Amount Year Area
  • 1,372,000,000
  • 2005
  • 1,604,000,000
  • 2007
  • 1,453,000,000
  • 2006
View entire collection »

Developed by:

Brand Names:

  • Xalatan

Stage of development:

Indication or disease:

Disease Phase of development
View entire collection »
top ↑

These people have edited this topic:

  • jg Metaweb Staff
Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Latanoprost was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution